{"id":"https://openalex.org/W1968073284","doi":"https://doi.org/10.1097/qad.0b013e3282f3356c","title":"IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages","display_name":"IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages","publication_year":2008,"publication_date":"2008-01-02","ids":{"openalex":"https://openalex.org/W1968073284","doi":"https://doi.org/10.1097/qad.0b013e3282f3356c","mag":"1968073284","pmid":"https://pubmed.ncbi.nlm.nih.gov/18090390"},"language":"en","primary_location":{"id":"doi:10.1097/qad.0b013e3282f3356c","doi":"https://doi.org/10.1097/qad.0b013e3282f3356c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3282f3356c","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089434852","display_name":"Tomozumi Imamichi","orcid":"https://orcid.org/0000-0002-1474-1796","observed_orcids":["https://orcid.org/0000-0002-1474-1796","https://orcid.org/0009-0007-0910-5297"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tomozumi Imamichi","raw_affiliation_strings":["Laboratory of Human Retrovirology, National Cancer Institute at Frederick, Frederick, Maryland, USA. timamichi@mail.nih.gov","Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","Laboratory of Human Retrovirology, National Cancer Institute at Frederick, Frederick, Maryland, USA","e-mail: [email\u00a0protected]","fax: +1 301 846 6762","to Tomozumi Imamichi, Building 550, Room 126, SAIC-Frederick, Inc., NCI-Frederick, PO Box B, Frederick, MD 21702-1201, USA. Tel: +1 301 846 5450"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Human Retrovirology, National Cancer Institute at Frederick, Frederick, Maryland, USA. timamichi@mail.nih.gov","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]},{"raw_affiliation_string":"Laboratory of Human Retrovirology, National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 301 846 6762","institution_ids":[]},{"raw_affiliation_string":"to Tomozumi Imamichi, Building 550, Room 126, SAIC-Frederick, Inc., NCI-Frederick, PO Box B, Frederick, MD 21702-1201, USA. Tel: +1 301 846 5450","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101558976","display_name":"Jun Yang","orcid":"https://orcid.org/0000-0003-2775-8914","observed_orcids":["https://orcid.org/0000-0003-2775-8914"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Yang","raw_affiliation_strings":["Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]},{"raw_affiliation_string":"Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101908661","display_name":"Da-Wei Huang","orcid":"https://orcid.org/0000-0003-0863-7535","observed_orcids":["https://orcid.org/0000-0003-0863-7535"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Da-Wei Huang","raw_affiliation_strings":["Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]},{"raw_affiliation_string":"Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039171889","display_name":"Terrence W. Brann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terrence W Brann","raw_affiliation_strings":["Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","Laboratory of Human Retrovirology, National Cancer Institute at Frederick, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]},{"raw_affiliation_string":"Laboratory of Human Retrovirology, National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013918494","display_name":"Brandie A. Fullmer","orcid":"https://orcid.org/0000-0002-0542-4959","observed_orcids":["https://orcid.org/0000-0002-0542-4959"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandie A Fullmer","raw_affiliation_strings":["Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]},{"raw_affiliation_string":"Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016588819","display_name":"Joseph W. Adelsberger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph W Adelsberger","raw_affiliation_strings":["AIDS Monitoring Laboratory, National Cancer Institute at Frederick, Frederick, Maryland, USA","Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AIDS Monitoring Laboratory, National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085875110","display_name":"Richard A. Lempicki","orcid":"https://orcid.org/0000-0002-7059-409X","observed_orcids":["https://orcid.org/0000-0002-7059-409X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A Lempicki","raw_affiliation_strings":["Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]},{"raw_affiliation_string":"Laboratory of Immunopathogenesis and Bioinformatics, National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040948574","display_name":"Michael Baseler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael W Baseler","raw_affiliation_strings":["Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Services Program, Applied and Developmental Research Support Program, Science Application International Corporation (SAIC)-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017815904","display_name":"Henry Clifford Lane","orcid":"https://orcid.org/0000-0001-9509-1045","observed_orcids":["https://orcid.org/0000-0001-9509-1045"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Clifford Lane","raw_affiliation_strings":["Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5089434852"],"corresponding_institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"],"apc_list":null,"apc_paid":null,"fwci":2.3583,"has_fulltext":false,"cited_by_count":101,"citation_normalized_percentile":{"value":0.88611111,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"22","issue":"1","first_page":"39","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.6528000235557556,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.6528000235557556,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.3379000127315521,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-27","display_name":"IL-27","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hiv-1-replication-inhibition","display_name":"HIV-1 replication inhibition","score":0.8700000047683716},{"id":"https://openalex.org/keywords/interferon-stimulated-genes","display_name":"interferon-stimulated genes","score":0.8339999914169312},{"id":"https://openalex.org/keywords/monocyte-derived-macrophages","display_name":"monocyte-derived macrophages","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9340000152587891},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8640000224113464},{"id":"https://openalex.org/keywords/antiviral-gene-expression","display_name":"antiviral gene expression","score":0.7630000114440918},{"id":"https://openalex.org/keywords/rna-dependent-protein-kinase","display_name":"RNA-dependent protein kinase","score":0.8669999837875366},{"id":"https://openalex.org/keywords/oligoadenylate-synthetase","display_name":"oligoadenylate synthetase","score":0.9810000061988831},{"id":"https://openalex.org/keywords/mx1","display_name":"MX1","score":0.5410000085830688},{"id":"https://openalex.org/keywords/apobec3g","display_name":"APOBEC3G","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.7461879253387451},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5777647495269775},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.5414848327636719},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5296950936317444},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.44590675830841064},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.43826013803482056},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.43615761399269104},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.39106500148773193},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3219933807849884},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2604895830154419},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15512195229530334},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14008045196533203},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07593485713005066}],"mesh":[{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005814","descriptor_name":"Genes, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D015967","descriptor_name":"Gene Expression Regulation, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017077","descriptor_name":"Culture Media, Conditioned","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020411","descriptor_name":"Oligonucleotide Array Sequence Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/qad.0b013e3282f3356c","doi":"https://doi.org/10.1097/qad.0b013e3282f3356c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3282f3356c","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:18090390","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18090390","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7699999809265137,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1356092923","display_name":null,"funder_award_id":"N01CO12400","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G174812244","display_name":"DCTD Computer Support","funder_award_id":"n01co12400-79-0-22","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1495948155","https://openalex.org/W1589212151","https://openalex.org/W1659719610","https://openalex.org/W1909719355","https://openalex.org/W1919902298","https://openalex.org/W1986370046","https://openalex.org/W1999561404","https://openalex.org/W2001375348","https://openalex.org/W2011370614","https://openalex.org/W2013015134","https://openalex.org/W2015440478","https://openalex.org/W2016956768","https://openalex.org/W2018712964","https://openalex.org/W2024588681","https://openalex.org/W2028702634","https://openalex.org/W2029303000","https://openalex.org/W2031286781","https://openalex.org/W2035027025","https://openalex.org/W2048283731","https://openalex.org/W2057592601","https://openalex.org/W2057812330","https://openalex.org/W2059250151","https://openalex.org/W2068577743","https://openalex.org/W2071103917","https://openalex.org/W2073242835","https://openalex.org/W2099074761","https://openalex.org/W2111980183","https://openalex.org/W2119986617","https://openalex.org/W2126197815","https://openalex.org/W2127154531","https://openalex.org/W2129292145","https://openalex.org/W2131162693","https://openalex.org/W2137051059","https://openalex.org/W2138366491","https://openalex.org/W2149473602","https://openalex.org/W2160063406","https://openalex.org/W2161299455","https://openalex.org/W2162123874","https://openalex.org/W2163942950","https://openalex.org/W2164259862","https://openalex.org/W2174193227","https://openalex.org/W2177943720","https://openalex.org/W2333908030","https://openalex.org/W2417331186","https://openalex.org/W4312850899","https://openalex.org/W6680809946"],"related_works":["https://openalex.org/W2083973986","https://openalex.org/W2414061256","https://openalex.org/W2037105562","https://openalex.org/W7095614432","https://openalex.org/W2009047406","https://openalex.org/W7095265191","https://openalex.org/W2053633009","https://openalex.org/W4408275164","https://openalex.org/W3106355511","https://openalex.org/W1982424156"],"abstract_inverted_index":{"OBJECTIVE:":[0],"IL-27":[1,176,194,213,225,237],"is":[2],"a":[3],"novel":[4],"anti-HIV":[5],"cytokine":[6],"that":[7,44,145,162,193,236,247],"inhibits":[8,238],"HIV-1":[9,81,121],"replication":[10,82,122,240],"in":[11,102,123,169,180,185,230,241],"both":[12],"CD4":[13,49,64,127,172,186,220],"T":[14,50,65,128,173,187,221],"cells":[15,42,51,60,66,222],"and":[16,35,52,71,139,148,166,171,182,204,223],"monocyte-derived":[17],"macrophages":[18],"(MDM)":[19],"as":[20,232],"IFN-alpha":[21,163],"does.":[22],"To":[23],"elucidate":[24],"the":[25,28,33,36,103,112,216],"mechanism":[26],"of":[27,40,45,61,105,197,248],"antiviral":[29,228],"activity,":[30],"we":[31],"compared":[32,125],"activity":[34],"gene":[37,91,217],"expression":[38,92,104,218],"profile":[39],"IL-27-treated":[41],"with":[43,69,126],"IFN-alpha-treated":[46],"cells.":[47,129,188],"METHODS:":[48],"monocytes":[53,76],"were":[54,67,73,94],"isolated":[55],"from":[56,75],"peripheral":[57],"blood":[58],"mononuclear":[59],"healthy":[62],"donors.":[63],"stimulated":[68],"phytohemagglutinin,":[70],"MDM":[72,124,170,181,231,242],"induced":[74,164,177],"using":[77,96,142],"macrophage-colony":[78],"stimulating":[79],"factor.":[80],"was":[83,109],"monitored":[84],"by":[85,111],"p24":[86],"antigen":[87],"capture":[88],"assay.":[89,115],"The":[90,100,189],"profiles":[93],"analysed":[95],"DNA":[97,158],"microarray":[98,159],"analysis.":[99],"increase":[101],"IFN-inducible":[106],"genes":[107,196,229],"(IFIG)":[108],"confirmed":[110,192],"Quantigene":[113],"plex":[114],"RESULTS:":[116],"Both":[117],"cytokines":[118],"preferentially":[119],"inhibited":[120],"Quantitative":[130],"real":[131],"time":[132],"polymerase":[133],"chain":[134],"reaction,":[135],"enzyme-linked":[136],"immunosorbent":[137],"assay":[138,141,191],"neutralization":[140],"anti-IFN":[143],"indicated":[144],"IFN-alpha,":[146,234],"IFN-beta":[147],"IFN-gamma":[149],"had":[150],"no":[151],"significant":[152],"impact":[153],"on":[154],"IL-27-mediated":[155],"HIV":[156,239],"inhibition.":[157],"analysis":[160],"illustrated":[161],"33":[165],"18":[167],"IFIG":[168,179,184],"cells,":[174],"respectively.":[175],"28":[178],"five":[183],"quantitative":[190],"activated":[195],"RNA-dependent":[198],"kinase,":[199],"oligoadenylate":[200],"synthetase,":[201],"myxovirus":[202],"protein,":[203],"apolipoprotein":[205],"B":[206],"messenger":[207],"RNA-editing":[208],"enzyme-catalytic":[209],"polypeptide-like":[210],"3G.":[211],"CONCLUSION:":[212],"differentially":[214],"regulates":[215],"between":[219],"MDM.":[224],"significantly":[226],"induces":[227],"does":[233],"suggesting":[235],"via":[243],"mechanism(s)":[244],"similar":[245],"to":[246],"IFN-alpha.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}